Aristotle Capital Management’s Gilead Sciences GILD Stock Holding History

Aristotle Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,025	Closed	-$493K	–	129
2015 Q3	$493K	Hold	5,025	–	–	0.01%	105
2015 Q2	$588K	Hold	5,025	–	–	0.01%	104
2015 Q1	$493K	Hold	5,025	–	–	0.01%	111
2014 Q4	$474K	Hold	5,025	–	–	0.01%	114
2014 Q3	$535K	Buy	5,025 +2,000	+66%	+$196K	0.01%	115
2014 Q2	$251K	Hold	3,025	–	–	﹤0.01%	150
2014 Q1	$214K	Hold	3,025	–	–	﹤0.01%	136
2013 Q4	$227K	Buy	+3,025	New	+$211K	﹤0.01%	132

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aristotle Capital Management's GILD Position: Q4 2015 in Review

Aristotle Capital Management sold out of Gilead Sciences (GILD) in Q4 2015, closing a stake of 5,025 shares — an estimated $493K sold.

Aristotle Capital Management first reported a position in GILD in Q4 2013 and held it in 8 quarters. The position peaked at $588K in Q2 2015. 1,627 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

Aristotle Capital Management reported no remaining Gilead Sciences position as of Q4 2015 after selling out during the quarter.
Aristotle Capital Management sold 5,025 Gilead Sciences shares in Q4 2015, an estimated $493K.
Aristotle Capital Management first reported a position in Gilead Sciences in Q4 2013 and held it in 8 quarters.
Aristotle Capital Management's Gilead Sciences position peaked at $588K in Q2 2015.
1,627 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Aristotle Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.